-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Pseudo-poo! All that glitters isn't fecal gold in Work In Progress
- This picture captures why "no sugar added" is a meaningless concept in Work In Progress
- "Oh no! What happened?" "W220.2XD: Walked into lamppost, subsequent encounter." in Work In Progress
- Our Brains as Alien Technology in Work In Progress
- Lab safety, smallpox and more virulent flu, marijuana benefits, plus headless, heedless, and clueless at Science in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.